HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,782,982 | +8.8% | 1,694,385 | +3.4% | 0.08% | +16.7% |
| Q2 2023 | $139,496,607 | +19.1% | 1,638,438 | +15.8% | 0.07% | +11.9% |
| Q1 2023 | $117,132,222 | +10.2% | 1,415,495 | +4.7% | 0.06% | +7.3% |
| Q4 2022 | $106,311,835 | +6.3% | 1,351,708 | +0.1% | 0.06% | +1.9% |
| Q3 2022 | $99,989,000 | +17.7% | 1,350,667 | +3.6% | 0.05% | +28.6% |
| Q2 2022 | $84,956,000 | -8.7% | 1,303,413 | -11.4% | 0.04% | +13.5% |
| Q1 2022 | $93,013,000 | +19.5% | 1,471,247 | +0.3% | 0.04% | +32.1% |
| Q4 2021 | $77,840,000 | -25.5% | 1,467,570 | -0.8% | 0.03% | -28.2% |
| Q3 2021 | $104,466,000 | +16.9% | 1,479,888 | +10.3% | 0.04% | +14.7% |
| Q2 2021 | $89,397,000 | -56.8% | 1,341,489 | -28.0% | 0.03% | -59.5% |
| Q1 2021 | $206,780,000 | -3.1% | 1,862,710 | +3.7% | 0.08% | -6.7% |
| Q4 2020 | $213,286,000 | +41.8% | 1,796,091 | +4.2% | 0.09% | +23.3% |
| Q3 2020 | $150,407,000 | +27.2% | 1,723,851 | +34.2% | 0.07% | +19.7% |
| Q2 2020 | $118,271,000 | +16.0% | 1,284,987 | +25.6% | 0.06% | -10.3% |
| Q1 2020 | $101,967,000 | -13.3% | 1,023,157 | -0.0% | 0.07% | +9.7% |
| Q4 2019 | $117,575,000 | -9.2% | 1,023,280 | -0.3% | 0.06% | -11.4% |
| Q3 2019 | $129,478,000 | +5.3% | 1,026,470 | +0.5% | 0.07% | +7.7% |
| Q2 2019 | $122,967,000 | +40.1% | 1,021,835 | +1.8% | 0.06% | +38.3% |
| Q1 2019 | $87,785,000 | -12.5% | 1,003,494 | +0.1% | 0.05% | -23.0% |
| Q4 2018 | $100,344,000 | -12.7% | 1,002,940 | +0.0% | 0.06% | +7.0% |
| Q3 2018 | $114,896,000 | +27.9% | 1,002,756 | +0.1% | 0.06% | +23.9% |
| Q2 2018 | $89,853,000 | +22.8% | 1,001,925 | +0.2% | 0.05% | +24.3% |
| Q1 2018 | $73,160,000 | +26.0% | 1,000,000 | 0.0% | 0.04% | +32.1% |
| Q4 2017 | $58,080,000 | +29.4% | 1,000,000 | 0.0% | 0.03% | +27.3% |
| Q3 2017 | $44,870,000 | +13.6% | 1,000,000 | 0.0% | 0.02% | +10.0% |
| Q2 2017 | $39,490,000 | -2.7% | 1,000,000 | 0.0% | 0.02% | -4.8% |
| Q1 2017 | $40,570,000 | +0.9% | 1,000,000 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $40,200,000 | +11.0% | 1,000,000 | 0.0% | 0.02% | +10.5% |
| Q3 2016 | $36,210,000 | +24.9% | 1,000,000 | 0.0% | 0.02% | +18.8% |
| Q2 2016 | $28,990,000 | -17.1% | 1,000,000 | 0.0% | 0.02% | -15.8% |
| Q1 2016 | $34,980,000 | +8.5% | 1,000,000 | 0.0% | 0.02% | +18.8% |
| Q4 2015 | $32,240,000 | -0.2% | 1,000,000 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $32,320,000 | -21.9% | 1,000,000 | 0.0% | 0.02% | -15.8% |
| Q2 2015 | $41,360,000 | -7.9% | 1,000,000 | 0.0% | 0.02% | -5.0% |
| Q1 2015 | $44,920,000 | +20.0% | 1,000,000 | 0.0% | 0.02% | +17.6% |
| Q4 2014 | $37,420,000 | +7.2% | 1,000,000 | -0.0% | 0.02% | +6.2% |
| Q3 2014 | $34,921,000 | -1.0% | 1,000,022 | +0.0% | 0.02% | 0.0% |
| Q2 2014 | $35,280,000 | +8.3% | 1,000,000 | 0.0% | 0.02% | +6.7% |
| Q1 2014 | $32,590,000 | -22.6% | 1,000,000 | 0.0% | 0.02% | -28.6% |
| Q4 2013 | $42,130,000 | +5.6% | 1,000,000 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $39,880,000 | -3.6% | 1,000,000 | 0.0% | 0.02% | -12.5% |
| Q2 2013 | $41,350,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |